$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 ... 8 9 10 11 12 13 14 15 16 ... 17 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.64 | 73 | 1,215 | 190,031 | 190.1 K to 190 K (-0.04 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.65 | 426 | 7,093 | 190,104 | 190.5 K to 190.1 K (-0.22 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.70 | 800 | 13,360 | 190,530 | 191.3 K to 190.5 K (-0.42 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.71 | 800 | 13,368 | 191,330 | 192.1 K to 191.3 K (-0.42 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.07 | 54 | 922 | 192,130 | 192.2 K to 192.1 K (-0.03 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.12 | 900 | 15,408 | 192,184 | 193.1 K to 192.2 K (-0.47 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.18 | 900 | 15,462 | 193,084 | 194 K to 193.1 K (-0.46 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.19 | 900 | 15,471 | 193,984 | 194.9 K to 194 K (-0.46 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.21 | 900 | 15,489 | 194,884 | 195.8 K to 194.9 K (-0.46 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.23 | 1,800 | 31,014 | 195,784 | 197.6 K to 195.8 K (-0.91 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.25 | 900 | 15,525 | 197,584 | 198.5 K to 197.6 K (-0.45 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.48 | 1,400 | 24,472 | 198,484 | 199.9 K to 198.5 K (-0.70 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.51 | 700 | 12,257 | 199,884 | 200.6 K to 199.9 K (-0.35 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.52 | 200 | 3,504 | 200,584 | 200.8 K to 200.6 K (-0.10 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.54 | 1,764 | 30,941 | 200,784 | 202.5 K to 200.8 K (-0.87 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.55 | 900 | 15,795 | 202,548 | 203.4 K to 202.5 K (-0.44 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.58 | 900 | 15,822 | 203,448 | 204.3 K to 203.4 K (-0.44 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.60 | 900 | 15,840 | 204,348 | 205.2 K to 204.3 K (-0.44 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.61 | 36 | 634 | 205,248 | 205.3 K to 205.2 K (-0.02 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.64 | 350 | 6,174 | 205,284 | 205.6 K to 205.3 K (-0.17 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.65 | 950 | 16,768 | 205,634 | 206.6 K to 205.6 K (-0.46 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.67 | 900 | 15,903 | 206,584 | 207.5 K to 206.6 K (-0.43 %) |
| Aug 14 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.75 | 900 | 15,975 | 207,484 | 208.4 K to 207.5 K (-0.43 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.68 | 200 | 3,336 | 28,139 | 28.3 K to 28.1 K (-0.71 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.70 | 200 | 3,340 | 28,339 | 28.5 K to 28.3 K (-0.70 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.73 | 200 | 3,346 | 28,539 | 28.7 K to 28.5 K (-0.70 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.83 | 200 | 3,366 | 28,739 | 28.9 K to 28.7 K (-0.69 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.98 | 200 | 3,396 | 28,939 | 29.1 K to 28.9 K (-0.69 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 17.04 | 200 | 3,408 | 29,139 | 29.3 K to 29.1 K (-0.68 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 17.06 | 200 | 3,412 | 29,339 | 29.5 K to 29.3 K (-0.68 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 17.09 | 200 | 3,418 | 29,539 | 29.7 K to 29.5 K (-0.67 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 17.23 | 625 | 10,769 | 29,739 | 30.4 K to 29.7 K (-2.06 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 17.58 | 200 | 3,516 | 30,364 | 30.6 K to 30.4 K (-0.65 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.68 | 1,000 | 16,680 | 208,384 | 209.4 K to 208.4 K (-0.48 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.70 | 3,000 | 50,100 | 209,384 | 212.4 K to 209.4 K (-1.41 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.75 | 1,000 | 16,750 | 212,384 | 213.4 K to 212.4 K (-0.47 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.76 | 1,000 | 16,760 | 213,384 | 214.4 K to 213.4 K (-0.47 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.80 | 1,000 | 16,800 | 214,384 | 215.4 K to 214.4 K (-0.46 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.84 | 1,000 | 16,840 | 215,384 | 216.4 K to 215.4 K (-0.46 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.85 | 1,000 | 16,850 | 216,384 | 217.4 K to 216.4 K (-0.46 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.86 | 1,000 | 16,860 | 217,384 | 218.4 K to 217.4 K (-0.46 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.91 | 1,000 | 16,910 | 218,384 | 219.4 K to 218.4 K (-0.46 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.96 | 100 | 1,696 | 219,384 | 219.5 K to 219.4 K (-0.05 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.98 | 1,000 | 16,980 | 219,484 | 220.5 K to 219.5 K (-0.45 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 16.99 | 1,000 | 16,990 | 220,484 | 221.5 K to 220.5 K (-0.45 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.01 | 2,000 | 34,020 | 221,484 | 223.5 K to 221.5 K (-0.89 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.02 | 104 | 1,770 | 223,484 | 223.6 K to 223.5 K (-0.05 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.03 | 1,000 | 17,030 | 223,588 | 224.6 K to 223.6 K (-0.45 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.04 | 100 | 1,704 | 224,588 | 224.7 K to 224.6 K (-0.04 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.05 | 100 | 1,705 | 224,688 | 224.8 K to 224.7 K (-0.04 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.09 | 800 | 13,672 | 224,788 | 225.6 K to 224.8 K (-0.35 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.17 | 1,000 | 17,170 | 225,588 | 226.6 K to 225.6 K (-0.44 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.20 | 1,000 | 17,200 | 226,588 | 227.6 K to 226.6 K (-0.44 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.23 | 1,000 | 17,230 | 227,588 | 228.6 K to 227.6 K (-0.44 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.24 | 3,000 | 51,720 | 228,588 | 231.6 K to 228.6 K (-1.30 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.25 | 1,000 | 17,250 | 231,588 | 232.6 K to 231.6 K (-0.43 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.28 | 796 | 13,755 | 232,588 | 233.4 K to 232.6 K (-0.34 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.29 | 1,000 | 17,290 | 233,384 | 234.4 K to 233.4 K (-0.43 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.62 | 1,000 | 17,620 | 234,384 | 235.4 K to 234.4 K (-0.42 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.63 | 2,000 | 35,260 | 235,384 | 237.4 K to 235.4 K (-0.84 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.65 | 1,000 | 17,650 | 237,384 | 238.4 K to 237.4 K (-0.42 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.66 | 1,100 | 19,426 | 238,384 | 239.5 K to 238.4 K (-0.46 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.67 | 900 | 15,903 | 239,484 | 240.4 K to 239.5 K (-0.37 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.68 | 1,000 | 17,680 | 240,384 | 241.4 K to 240.4 K (-0.41 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.70 | 1,000 | 17,700 | 241,384 | 242.4 K to 241.4 K (-0.41 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.71 | 2,000 | 35,420 | 242,384 | 244.4 K to 242.4 K (-0.82 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.74 | 3,400 | 60,316 | 244,384 | 247.8 K to 244.4 K (-1.37 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.75 | 400 | 7,100 | 247,784 | 248.2 K to 247.8 K (-0.16 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.77 | 2,000 | 35,540 | 248,184 | 250.2 K to 248.2 K (-0.80 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.78 | 1,000 | 17,780 | 250,184 | 251.2 K to 250.2 K (-0.40 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.79 | 436 | 7,756 | 251,184 | 251.6 K to 251.2 K (-0.17 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.80 | 1,664 | 29,619 | 251,620 | 253.3 K to 251.6 K (-0.66 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.82 | 1,000 | 17,820 | 253,284 | 254.3 K to 253.3 K (-0.39 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.83 | 1,356 | 24,177 | 254,284 | 255.6 K to 254.3 K (-0.53 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.84 | 256 | 4,567 | 255,640 | 255.9 K to 255.6 K (-0.10 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.87 | 100 | 1,787 | 255,896 | 256 K to 255.9 K (-0.04 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.88 | 1,000 | 17,880 | 255,996 | 257 K to 256 K (-0.39 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.93 | 1,644 | 29,477 | 256,996 | 258.6 K to 257 K (-0.64 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.94 | 744 | 13,347 | 258,640 | 259.4 K to 258.6 K (-0.29 %) |
| Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.99 | 1,000 | 17,990 | 259,384 | 260.4 K to 259.4 K (-0.38 %) |
| Aug 07 2007 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 18.21 | 10,000 | 182,100 | 10,000 | |
| Aug 07 2007 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 18.21 | 10,000 | 182,100 | 10,000 | |
| Aug 07 2007 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 18.21 | 10,000 | 182,100 | 10,000 | |
| Aug 07 2007 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Option Exercise | A | 18.21 | 10,000 | 182,100 | 10,000 | |
| Aug 07 2007 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 18.21 | 10,000 | 182,100 | 10,000 | |
| Aug 07 2007 | ACOR | ACORDA THERAPEUTIC ... | YOUNG WISE | Director | Option Exercise | A | 18.21 | 10,000 | 182,100 | 10,000 | |
| Aug 07 2007 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 18.21 | 10,000 | 182,100 | 10,000 | |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.24 | 1,000 | 17,240 | 57,230 | 58.2 K to 57.2 K (-1.72 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.52 | 500 | 8,760 | 58,230 | 58.7 K to 58.2 K (-0.85 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.60 | 500 | 8,800 | 58,730 | 59.2 K to 58.7 K (-0.84 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.68 | 100 | 1,768 | 59,230 | 59.3 K to 59.2 K (-0.17 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.70 | 500 | 8,850 | 59,330 | 59.8 K to 59.3 K (-0.84 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.71 | 300 | 5,313 | 59,830 | 60.1 K to 59.8 K (-0.50 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.72 | 100 | 1,772 | 60,130 | 60.2 K to 60.1 K (-0.17 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.73 | 500 | 8,865 | 60,230 | 60.7 K to 60.2 K (-0.82 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.74 | 500 | 8,870 | 60,730 | 61.2 K to 60.7 K (-0.82 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.75 | 600 | 10,650 | 61,230 | 61.8 K to 61.2 K (-0.97 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.76 | 800 | 14,208 | 61,830 | 62.6 K to 61.8 K (-1.28 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.78 | 100 | 1,778 | 62,630 | 62.7 K to 62.6 K (-0.16 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.79 | 500 | 8,895 | 62,730 | 63.2 K to 62.7 K (-0.79 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.81 | 1,000 | 17,810 | 63,230 | 64.2 K to 63.2 K (-1.56 %) |
| Jul 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 17.85 | 500 | 8,925 | 64,230 | 64.7 K to 64.2 K (-0.77 %) |
| Jun 18 2007 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 18.48 | 23,708 | 438,178 | 595,846 | 619.6 K to 595.8 K (-3.83 %) |
| Jun 18 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 18.48 | 2,007 | 37,087 | 14,052 | 16.1 K to 14.1 K (-12.50 %) |
| Jun 15 2007 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.50 | 3,040 | 56,240 | 40,752 | 43.8 K to 40.8 K (-6.94 %) |
| Jun 14 2007 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 18.50 | 120,000 | 2,220,000 | 619,554 | 739.6 K to 619.6 K (-16.23 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.40 | 500 | 9,700 | 64,730 | 65.2 K to 64.7 K (-0.77 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.41 | 1,900 | 36,879 | 65,230 | 67.1 K to 65.2 K (-2.83 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.45 | 500 | 9,725 | 67,130 | 67.6 K to 67.1 K (-0.74 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.46 | 500 | 9,730 | 67,630 | 68.1 K to 67.6 K (-0.73 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.47 | 500 | 9,735 | 68,130 | 68.6 K to 68.1 K (-0.73 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.48 | 100 | 1,948 | 68,630 | 68.7 K to 68.6 K (-0.15 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.52 | 1,000 | 19,520 | 68,730 | 69.7 K to 68.7 K (-1.43 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.64 | 500 | 9,820 | 69,730 | 70.2 K to 69.7 K (-0.71 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.77 | 500 | 9,885 | 70,230 | 70.7 K to 70.2 K (-0.71 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.80 | 17 | 337 | 70,730 | 70.7 K to 70.7 K (-0.02 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.90 | 100 | 1,990 | 70,747 | 70.8 K to 70.7 K (-0.14 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 19.99 | 500 | 9,995 | 70,847 | 71.3 K to 70.8 K (-0.70 %) |
| Jun 05 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 20.13 | 883 | 17,775 | 71,347 | 72.2 K to 71.3 K (-1.22 %) |
| May 24 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 24.11 | 283 | 6,823 | 17,424 | 17.7 K to 17.4 K (-1.60 %) |
| May 24 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 24.12 | 400 | 9,648 | 17,707 | 18.1 K to 17.7 K (-2.21 %) |
| May 24 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 24.38 | 200 | 4,876 | 18,107 | 18.3 K to 18.1 K (-1.09 %) |
| May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 24.13 | 300 | 7,239 | 30,564 | 30.9 K to 30.6 K (-0.97 %) |
| May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 24.32 | 200 | 4,864 | 30,864 | 31.1 K to 30.9 K (-0.64 %) |
| May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 24.61 | 300 | 7,383 | 31,064 | 31.4 K to 31.1 K (-0.96 %) |
| May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 24.63 | 300 | 7,389 | 31,364 | 31.7 K to 31.4 K (-0.95 %) |
| May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 24.96 | 300 | 7,488 | 31,664 | 32 K to 31.7 K (-0.94 %) |
| May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 25.00 | 300 | 7,500 | 31,964 | 32.3 K to 32 K (-0.93 %) |
| May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 25.04 | 300 | 7,512 | 32,264 | 32.6 K to 32.3 K (-0.92 %) |
| May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 25.06 | 300 | 7,518 | 32,564 | 32.9 K to 32.6 K (-0.91 %) |
| May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 25.07 | 300 | 7,521 | 32,864 | 33.2 K to 32.9 K (-0.90 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 23.86 | 500 | 11,930 | 72,230 | 72.7 K to 72.2 K (-0.69 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 23.88 | 500 | 11,940 | 72,730 | 73.2 K to 72.7 K (-0.68 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.06 | 600 | 14,436 | 73,230 | 73.8 K to 73.2 K (-0.81 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.08 | 400 | 9,632 | 73,830 | 74.2 K to 73.8 K (-0.54 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.15 | 500 | 12,075 | 74,230 | 74.7 K to 74.2 K (-0.67 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.20 | 500 | 12,100 | 74,730 | 75.2 K to 74.7 K (-0.66 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.25 | 500 | 12,125 | 75,230 | 75.7 K to 75.2 K (-0.66 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.26 | 1,000 | 24,260 | 75,730 | 76.7 K to 75.7 K (-1.30 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.29 | 500 | 12,145 | 76,730 | 77.2 K to 76.7 K (-0.65 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.31 | 500 | 12,155 | 77,230 | 77.7 K to 77.2 K (-0.64 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.34 | 500 | 12,170 | 77,730 | 78.2 K to 77.7 K (-0.64 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.44 | 400 | 9,776 | 78,230 | 78.6 K to 78.2 K (-0.51 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.45 | 100 | 2,445 | 78,630 | 78.7 K to 78.6 K (-0.13 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.56 | 457 | 11,224 | 78,730 | 79.2 K to 78.7 K (-0.58 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.57 | 500 | 12,285 | 79,187 | 79.7 K to 79.2 K (-0.63 %) |
| May 01 2007 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 24.91 | 43 | 1,071 | 79,687 | 79.7 K to 79.7 K (-0.05 %) |
| Apr 25 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.65 | 200 | 4,730 | 18,307 | 18.5 K to 18.3 K (-1.08 %) |
| Apr 25 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.75 | 200 | 4,750 | 18,507 | 18.7 K to 18.5 K (-1.07 %) |
| Apr 25 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 24.00 | 83 | 1,992 | 18,707 | 18.8 K to 18.7 K (-0.44 %) |